Invega Sustenna 100mg Injection
Marketer
Janssen Pharmaceuticals
Salt Composition
Paliperidone (100mg)
Overview Invega Sustenna 100mg Injection
Paliperidone palmitate 100mg injection treats schizophrenia (a mental illness causing hallucinations, delusions, and impaired thinking/behavior) and manic episodes. Administered by a healthcare provider, consistent daily dosing maintains therapeutic levels. Sudden discontinuation is unsafe and may exacerbate symptoms; however, stop immediately if neuroleptic malignant syndrome (NMS) occurs (fever, muscle stiffness, altered mental state). Common side effects include injection site reactions (pain, swelling, redness), involuntary eye movements (nystagmus), tremor, dizziness, and drowsiness; avoid driving or activities requiring alertness until effects are known. Increased diabetes risk necessitates regular glucose monitoring. Report any unusual mood changes, new or worsening depression, or suicidal thoughts to your doctor. A patient assistance program exists in India, managed by Tata 1mg; consult your physician or call (1800-102-1618) for details.
Primary Ingredients of Invega Sustenna 100mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Invega Sustenna 100mg Injection
Psychotic disorders exhibiting schizophrenic or manic features
Major Benefits of Invega Sustenna 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Invega Sustenna 100mg Injection:
- Abnormal involuntary movements
- Dizziness
- Injection site reactions (pain, swelling, redness)
- Nystagmus (involuntary eye movement)
- Sleepiness
- Tremors
How to use Invega Sustenna 100mg Injection:
This medication will be administered by your physician or their registered nurse; self-medication is strictly prohibited.
How Invega Sustenna 100mg Injection works:
Xeplion 100mg, an atypical antipsychotic injection, modifies neurotransmitter levels (dopamine and serotonin), thereby enhancing cognitive function, emotional stability, and behavioral control.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Invega Sustenna 100mg Injection is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Invega Sustenna 100mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while using Invega Sustenna 100mg Injection is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
The administration of Invega Sustenna 100mg Injection can potentially reduce vigilance, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCAUTION
Patients with kidney impairment should receive Invega Sustenna 100mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Invega Sustenna 100mg Injection is contraindicated in individuals with terminal kidney disease.
LiverCAUTION
Patients with severe hepatic impairment should use Invega Sustenna 100mg Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Data regarding its use in such patients is limited; however, dosage alteration isn't advised for those with mild to moderate liver disease.
What if you forget to take Invega Sustenna 100mg Injection :
NA
Facts to Know About Invega Sustenna 100mg Injection
| Label | Value |
|---|---|
| Chemical Type | Benzisoxazole analog |
| Developing Habits | No. |
| Type of Therapy | Central Nervous System (CNS) Neurology |
| Action Category | Nontypical Antipsychotics |


